Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Onyx Weight Loss vs PepHaūs

Onyx Weight Loss
Graded #358

Lower grade

vs+23.900000000000006
PepHaūs
Graded #32

Higher grade

The verdict

PepHaūs takes it — 82.7/100 to 58.8/100.

PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Verified and nationwide, but priced in the upper-mid band ($152/$246).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePepHaūs +39
43
82
Dose & formulationPepHaūs +16
64
80
Clinical oversightPepHaūs +9
75
84
Labs & monitoringPepHaūs +19
63
82
FulfillmentPepHaūs +33
53
86
Contract termsPepHaūs +30
55
85
Onyx Weight Loss · left barPepHaūs · right bar

The numbers

MetricOnyx Weight LossPepHaūs
WeighScore58.8/10082.7/100
GradeCB−
Scorecard rank#358#32
Semaglutide$228/mo (starting dose, compounded)$152/mo
Tirzepatide$280/mo (starting dose, compounded)$246/mo
Coverage8 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Onyx Weight Loss

Graded #358 · C

Strengths

  • Competitive entry pricing: semaglutide from $228/mo and tirzepatide from $280/mo with medication + supplies included
  • Nurse-practitioner-led care: founder Tasha Vangile FNP-C (20+ years) and Stephanie Robison APRN-CNP (27 years experience)
  • Low-cost $99/mo GLP-1 microdosing option for patients who prefer a gradual titration start
  • Strive Pharmacy partnership implies compounded 503A-quality supply chain from a known pharmacy
  • Multi-modal clinic: GLP-1 + peptides + HRT + nutrition coaching available under one provider team

Where it loses points

  • Only 8 states (NC, CO, ME, VT, VA, IA, NH, PA) — excludes the majority of the US
  • No LegitScript certification; credentialing evidence limited to local 2025 Best of Iredell award
  • Specific drug names (semaglutide/tirzepatide) never stated on website; compounded status inferred, not disclosed
  • Labs not included or mentioned; no baseline bloodwork protocol published
  • Pricing shown as 'Starting at' with no dose-escalation tier pricing disclosed publicly
PepHaūs

Graded #32 · B−

Strengths

  • LegitScript-verified, all 50 states
  • Both molecules
  • Transparent listed pricing

Where it loses points

  • Upper-mid pricing ($152/$246)
  • Injection-only
  • Monitoring detail limited

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard